NCT00023855 2019-12-13
PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors
University of Wisconsin, Madison
Phase 1 Completed
Clinical Trials
7 trialsNCT00290680 2018-04-10
Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors
Medical University of South Carolina
Phase 1 Completed
NCT00541359 2017-08-09
Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors
City of Hope Medical Center
Phase 1 Completed
NCT02220049 2016-03-25
VELDAY
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Completed
NCT01497626 2016-02-17
Lapatinib and Bortezomib in Patients With Advanced Malignancies
Georgetown University
Phase 1 Terminated
NCT00720148 2014-08-26
A Phase I Trial of Bortezomib and Sunitinib
Emory University
Phase 1 Completed
NCT00500422 2013-02-13
Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Completed